Transforming growth factor-beta as a target for treatment in diabetic nephropathy.
Basile
D P
DP
Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. dbasile@mcw.edu
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D005355:Fibrosis; D006801:Humans; D007668:Kidney / Q000378:metabolism; D051379:Mice; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors* / Q000502:physiology
D000911:Antibodies, Monoclonal; D016212:Transforming Growth Factor beta